| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.61 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.008 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |